KYTX vs VNO · $488.8M cap vs rev $921.3M
Kyverna Therapeutics, Inc. Common Stock (KYTX) versus VNO (VNO) — a side-by-side from cached financials, not a winner call.
Kyverna Therapeutics, Inc. Common Stock (KYTX) is a biotechnology company listed on NASDAQ.
VNO (VNO) common stock.
KYTX does not have a complete income-statement cache yet.
Latest reported VNO revenue for 2026-06-30 was $921.3M. Net income was $24.6M. VNO currently screens at market cap $0.
KYTX currently screens at market cap $488.8M. VNO currently screens at market cap $0.
Not investment advice. Open the KYTX and VNO stock pages for the full models.
Not investment advice.